Resources

This document provides an overview of the global, multisectoral Coalition for Access to NCD Medicines & Products. The coalition is dedicated to increasing access to essential medicines and health products to reduce the impact of noncommunicable diseases (NCDs) such as diabetes and cardiovascular disease.

The Cryptosporidium parasite is one of the leading causes of diarrheal disease among young children. This report shares highlights from PATH’s 2nd Symposium on Innovative Therapeutics for Cryptosporidium, where experts presented about the state of work in discovery, development, and commercialization of innovative treatments.

Assessment and recommendations to increase access to oxygen and pulse oximetry in Kenya

Market assessment and recommendations to increase access to oxygen and pulse oximetry in India

The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments, and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This report presents findings synthesized across six of the eight PCE countries in 2017 and describes the overall PCE design, progress, and early findings, with a focus on the funding request and grant-making stages. Key themes explored through this report included an exploration of how Global Fund business model is implemented in-country and the translation of Global Fund strategy and policy in-country.